You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

evolocumab

Showing 26 - 50 of 70
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

STEMI, Dyslipidemias Trial (Evolocumab)

Not yet recruiting
  • STEMI
  • Dyslipidemias
  • Evolocumab
  • (no location specified)
Oct 12, 2022

ASCVD, Atherosclerotic Cardiovascular Disease, Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Trial (Evolocumab,

Not yet recruiting
  • ASCVD
  • +3 more
  • (no location specified)
Aug 3, 2023

Stable Coronary Disease Trial (Evolocumab)

Not yet recruiting
  • Stable Coronary Disease
  • Evolocumab
  • (no location specified)
Dec 16, 2021

Coronary Artery Disease (CAD) Trial in Worldwide (Evolocumab, Placebo, Statin therapy)

Completed
Has Results
  • Coronary Artery Disease (CAD)
  • Evolocumab
  • +2 more
  • Los Angeles, California
  • +32 more
Apr 7, 2022

Subclinical Atherosclerosis in Familial Hypercholesterolemia

Recruiting
  • Hypercholesterolemia, Familial
  • Evolocumab
  • Napoli, Italy
    Matteo Di Minno
Mar 4, 2021

Hereditary Spastic Paraplegia Type 5 Trial in Fuzhou (evolocumab)

Recruiting
  • Hereditary Spastic Paraplegia Type 5
  • evolocumab
  • Fuzhou, China
    Department of Neurology , First Affiliated Hospital Fujian Medic
Nov 21, 2021

Hypercholesterolemia; ASCVD; Pregnancy Trial (evolocumab)

Terminated
  • Hypercholesterolemia; ASCVD; Pregnancy
  • evolocumab
  • (no location specified)
Dec 15, 2020

Hypercholesterolemia, CKD Stage 5, Chronic Kidney Disease Requiring Chronic Dialysis Trial in Rome (Evolocumab, Ezetimibe,

Recruiting
  • Hypercholesterolemia
  • +2 more
  • Evolocumab
  • +2 more
  • Rome, Italy
    Policlinico Casilino
Dec 13, 2020

Cardiac Allograft Vasculopathy Trial in Denmark, Finland, Sweden (Evolocumab, Placebo)

Recruiting
  • Cardiac Allograft Vasculopathy
  • Evolocumab
  • Placebo
  • Copenhagen, Denmark
  • +4 more
Feb 25, 2021

Primary Hypercholesterolemia, Mixed Dyslipidemia Trial in China (evolocumab, )

Terminated
Has Results
  • Primary Hypercholesterolemia
  • Mixed Dyslipidemia
  • evolocumab
  • placebo
  • Beijing, Beijing, China
  • +30 more
Oct 7, 2021

Acute Coronary Syndrome, Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Trial in Tianjin (Evolocumab)

Recruiting
  • Acute Coronary Syndrome
  • Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor
  • Evolocumab
  • Tianjin, China
    Tianjin Chest Hospital,
Nov 20, 2020

Familial Hypercholesterolemia Trial in New York (Evolocumab)

Terminated
Has Results
  • Familial Hypercholesterolemia
  • Evolocumab
  • New York, New York
    Columbia University Medical Center
Mar 5, 2021

Research With PCSK9 Inhibition in High Risk Coronary Artery

Unknown status
  • Dyslipidemia
  • High Risk Coronary Artery Disease
  • Evolocumab
  • Beijing, Beijing, China
    Beijing Anzhen Hospital, Capital Medical University
Dec 1, 2020

Human Immunodeficiency Virus, Coronary Artery Disease Trial in Baltimore (Evolocumab)

Completed
Has Results
  • Human Immunodeficiency Virus
  • Coronary Artery Disease
  • Evolocumab
  • Baltimore, Maryland
    Johns Hopkins University
Jul 23, 2020

Atherosclerotic Cardiovascular Disease, Symptomatic Atherosclerosis, Type2 Diabetes Trial in Worldwide (Inclisiran, Evolocumab)

Completed
  • Atherosclerotic Cardiovascular Disease
  • +3 more
  • Jacksonville, Florida
  • +51 more
Feb 7, 2022

Homozygous Familial Hypercholesterolemia HoFH Trial in India (evolocumab)

Completed
Has Results
  • Homozygous Familial Hypercholesterolemia HoFH
  • evolocumab
  • New Delhi, Delhi, India
  • +11 more
Nov 13, 2020

Hyperlipidemia Trial in Worldwide (biological, drug, other)

Completed
Has Results
  • Hyperlipidemia
  • Evolocumab
  • +3 more
  • Birmingham, Alabama
  • +82 more
Nov 4, 2022

Kideny Transplant Recipients With High Cardiovascular Risk Score Trial in Kuwait (Evolocumab)

Completed
  • Kideny Transplant Recipients With High Cardiovascular Risk Score
  • Evolocumab
  • Kuwait, Kuwait
    OTC, MOH , Kuwait
Dec 7, 2020

Hypercholesterolemia Trial in Worldwide (biological, drug, other)

Completed
Has Results
  • Hypercholesterolemia
  • Evolocumab
  • +4 more
  • Birmingham, Alabama
  • +95 more
Jul 15, 2022

Coronary Artery Bypass Graft Surgery, Atherosclerosis, Vein Occlusion Trial in Canada, United States (Evolocumab, Placebo)

Recruiting
  • Coronary Artery Bypass Graft Surgery
  • +2 more
  • Evolocumab
  • Placebo
  • New Haven, Connecticut
  • +8 more
Jul 9, 2020

Hypercholesterolemia Trial in Japan (Evolocumab, Ezetimibe, Placebo to Evolocumab)

Completed
Has Results
  • Hypercholesterolemia
  • Evolocumab
  • +3 more
  • Nagoya-shi, Aichi, Japan
  • +34 more
Oct 20, 2020

Dyslipidemia Trial in Worldwide (Evolocumab)

Completed
  • Dyslipidemia
  • Evolocumab
  • Aalst, Belgium
  • +84 more
Mar 8, 2022

Acute Coronary Syndrome, Premature Coronary Heart Disease, Lipoproteinemia Trial in Ljubljana (Alirocumab, Evolocumab, Control

Unknown status
  • Acute Coronary Syndrome
  • +4 more
  • Ljubljana, Slovenia
    University Medical Centre Ljubljana-Department of Vascular disea
Oct 27, 2020

Hyperlipidemia Trial in Worldwide (biological, drug, other)

Completed
Has Results
  • Hyperlipidemia
  • Evolocumab
  • +2 more
  • Anaheim, California
  • +41 more
Jan 4, 2021

Coronary Artery Disease, Atherosclerosis, Hyperlipidemias Trial in London (Evolocumab, Placebo)

Unknown status
  • Coronary Artery Disease
  • +2 more
  • Evolocumab
  • Placebo
  • London, United Kingdom
    Imperial College NHS Foundation Trust
Dec 11, 2019